Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


21.08.2017

1 Anticancer Drugs
2 Br J Cancer
4 Cancer
1 Clin Cancer Res
4 Gynecol Oncol
1 Hum Pathol
1 Int J Cancer
1 Oncogene
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Drugs

  1. REEVES PM, Abbaslou MA, Kools FRW, Poznansky MC, et al
    CXCR4 blockade with AMD3100 enhances Taxol chemotherapy to limit ovarian cancer cell growth.
    Anticancer Drugs. 2017 Aug 16. doi: 10.1097/CAD.0000000000000518.
    PubMed     Text format     Abstract available


    Br J Cancer

  2. MINLIKEEVA AN, Freudenheim JL, Cannioto RA, Eng KH, et al
    History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.
    Br J Cancer. 2017 Aug 17. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  3. CHEN Y, Wang DD, Wu YP, Su D, et al
    MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells.
    Br J Cancer. 2017 Aug 17. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  4. BUYS SS, Sandbach JF, Gammon A, Patel G, et al
    A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
    Cancer. 2017 Jan 13. doi: 10.1002/cncr.30498.
    PubMed     Text format     Abstract available

  5. ZENNARO L, Vanzani P, Nicole L, Cappellesso R, et al
    Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers.
    Cancer. 2017;125:341-348.
    PubMed     Text format     Abstract available

  6. STIEKEMA A, Van de Vijver KK, Boot H, Broeks A, et al
    Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Mullerian origin from gastrointestinal cancer.
    Cancer. 2017;125:197-204.
    PubMed     Text format     Abstract available

  7. LONG ROCHE KC, Abu-Rustum NR, Nourmoussavi M, Zivanovic O, et al
    Risk-reducing salpingectomy: Let us be opportunistic.
    Cancer. 2017;123:1714-1720.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  8. RAGHAVAN S, Mehta P, Ward MW, Bregenzer ME, et al
    Personalized Medicine Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.
    Clin Cancer Res. 2017 Aug 16. pii: clincanres.0133.2017.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  9. TATE S, Kato K, Nishikimi K, Matsuoka A, et al
    Survival and safety associated with aggressive surgery for stage III/IV epithelial ovarian cancer: A single institution observation study.
    Gynecol Oncol. 2017 Aug 8. pii: S0090-8258(17)31176.
    PubMed     Text format     Abstract available

  10. KNAPP P, Bodnar L, Blachnio-Zabielska A, Swiderska M, et al
    Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer.
    Gynecol Oncol. 2017 Aug 8. pii: S0090-8258(17)31183.
    PubMed     Text format     Abstract available

  11. FORTNER RT, Damms-Machado A, Kaaks R
    Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.
    Gynecol Oncol. 2017 Aug 8. pii: S0090-8258(17)31178.
    PubMed     Text format     Abstract available

  12. OLIVER KE, Brady WE, Birrer M, Gershenson DM, et al
    An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
    Gynecol Oncol. 2017 Aug 11. pii: S0090-8258(17)31226.
    PubMed     Text format     Abstract available


    Hum Pathol

  13. WANG WC, Lai YC
    Genetic analysis results of mature cystic teratomas of the ovary in Taiwan disagree with the previous origin theory of this tumor.
    Hum Pathol. 2016;52:128-35.
    PubMed     Text format     Abstract available


    Int J Cancer

  14. WU YH, Huang YF, Chang TH, Chou CY, et al
    Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-kappaB-mediated IKKbeta expression.
    Int J Cancer. 2017 Aug 17. doi: 10.1002/ijc.30932.
    PubMed     Text format     Abstract available


    Oncogene

  15. SOMASAGARA RR, Spencer SM, Tripathi K, Clark DW, et al
    RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.
    Oncogene. 2017 Aug 14. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  16. KODAMA M, Kodama T, Newberg JY, Katayama H, et al
    In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.
    Proc Natl Acad Sci U S A. 2017 Aug 15. pii: 201705441.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: